![](https://emil-med.de/wp-content/uploads/2023/07/Abluminus-DES.jpg)
Abluminus DES+
Sirolimus Coated Coronary Stent
ABLUMINUS DES+ was developed from proprietary ENVISOLUTION technology to address unmet clinical needs in patients with diabetes mellitus and acute myocardial infarction with coronary artery disease.
![](https://emil-med.de/wp-content/uploads/2023/07/csm_conceptmedicallogo.png)
Envisolution Technology
![](https://emil-med.de/wp-content/uploads/2023/07/Abluminus-DES-Feature1-150x150.jpg)
Abluminal Coting facilitates directional drug release and less systemic exposure of drug leading to faster re-endothelialisation
![](https://emil-med.de/wp-content/uploads/2023/07/Abluminus-DES-Feature2-150x150.jpg)
Fusion Coating - Coating on the stent and exposed parts of the balloon facilitate homogenous drug delivery which address diffused proliferative disease and focal restenosis
![](https://emil-med.de/wp-content/uploads/2023/07/Abluminus-DES-Feature3-150x150.jpg)
Edge Coating - The extra 0,5mm coating on the edge of the balloon which addresses the edge restenosis
![](https://emil-med.de/wp-content/uploads/2023/07/Abluminus-DES-Feature4-150x150.jpg)
Biodegradable Film - The formation of Sirolimus circular film with biodegradable polymer facilitates maximum drug delivery